Knockdown of LRPPRC led to decreased levels of OXPHOS and tumorigenicity in OC cells, supporting the utility of LRPPRC suppression as a novel strategy for ovarian cancer management. The gene discussed is LRPPRC; the disease is ovarian cancer.